Live Breaking News & Updates on Biotech Chairman

Stay updated with breaking news from Biotech chairman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Is Covaxin safe for children? Here's what Bharat Biotech has to say

Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study. ....

New Delhi , Krishna Ella , Bharat Biotech International Ltd On , Bharat Biotech International Ltd , Central Drugs Standard Control Organisation , Lancet Infectious , Biotech Chairman ,

Bharat Biotech To Get $19 Million For Development Of 'Variant Proof' Covid Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a "variant-proof" SARS-CoV-2 vaccine candidate. ....

New South Wales , Richard Hatchett , Krishna Ella , Bharat Biotech International , Coalition For Epidemic Preparedness Innovations , University Of Sydney , Covaxin Maker Gets , Variant Proof Vaccine , Epidemic Preparedness Innovations , Switzerland Based Excellgene , Bharat Biotech , Biotech Chairman , Managing Director Krishna Ella ,

Covaxin booster dose neutralises Omicron Delta Covid variants Bharat Biotech

Covaxin ( BBV152) booster, India s indigenous vaccine, has shown that it can neutralize both Omicron and Delta variants of SARS-CoV-2, jab maker Bharat Biotech informed on Wednesday. ....

Krishna Ella , Image Source , Bharat Biotech , Biotech Chairman , Managing Director Krishna Ella , Bharat Biotech , Ovaxin Booster Shot , Covaxin Covid Vaccine , Omicron Variant , Delta Variant ,